Private Equity Outlook: Rate Cuts, Mid-Market Activity, and Investment Trends with Richard Kes 10-21-24
In this episode, Scott Becker interviews Richard Kes, Partner at RSM, about the impact of recent rate cuts, growing deal activity in the mid-market, and key trends driving private equity. Kes shares insights on the cautious optimism in the market and the factors influencing investment decisions across industries and regions.
Bob Iger vs. Charlamagne tha God: A Tale of Ego, Leadership, and Disney’s Future 10-21-24
In this episode, Scott Becker explores the parallels between Disney CEO Bob Iger and Charlemagne, diving into leadership, ego, and the challenges of running a modern empire. He also discusses Disney’s performance, its struggles with the parks business, and Iger’s upcoming departure.
Market Insights: Acadia’s Challenges, Intuitive’s Growth, and Peloton’s Market Jump 10-21-24
In this episode, Scott Becker covers Acadia Healthcare’s challenging year, Intuitive’s rise, and Peloton’s surprising market jump. He also touches on the struggles of powerhouse football programs Michigan and Alabama, along with a preview of the sold-out Becker’s Healthcare CEO Roundtable.
Markets Pointing Down: 7 Business News Stories to Watch 10-21-24
In this episode, Scott Becker highlights seven key market stories, including the struggles of Spirit Airlines, NVIDIA’s remarkable 180% rise, and the contrasting fortunes of Tesla and United Health Group. Tune in for updates on major market movers and expert insights.
Citigroup’s Slump and WD-40’s Slide: A Closer Look at Two Struggling Stocks 10-19-24
In this episode, Scott Becker discusses the challenges faced by Citigroup and WD-40, with both stocks taking a hit this week despite overall strong year-to-date performances. Tune in for insights into Citigroup’s recent profitability dip and WD-40’s struggles, plus quick updates on Apple and Tesla.
Matt Wolf of RSM on Surging Private Equity Activity and Strategic Shifts 10-18-24
In this episode, Matt Wolf, Healthcare Senior Analyst and National Health Care Business Valuation Leader at RSM, joins Scott Becker to discuss the latest trends in private equity. Matt shares insights on the recent surge in deal volume, the impact of interest rates on diligence, and how sponsors are adapting their strategies in today’s changing […]
Netflix’s Growth, Intuitive Surgical’s Rise, and CVS’s Challenges 10-18-24
In this episode, Scott Becker covers Netflix’s impressive turnaround, Intuitive Surgical’s strong performance, CVS’s CEO change and stock dip, and American Express’s slight drop despite a strong year. Listen for insights on these key market moves and more.
Another One Bites the Dust: CVS CEO Change, Amazon’s Office Mandate, and More
In this episode, Scott Becker covers five key business stories, including CVS replacing CEO Karen Lynch, Amazon’s push for employees to return to the office, and Ferrari’s new $3.9 million sports car. Also discussed are the latest U.S. presidential poll updates and Lucid Motors’ financial struggles.
What Lucid Motors Can Learn from Jack Welch’s Legacy 10-17-24
In this episode, Scott Becker explores how Lucid Motors, the third-largest EV maker, could apply lessons from legendary CEO Jack Welch’s strategy at General Electric. Becker discusses the importance of being number one or two in the market, challenges Lucid faces as it lags behind Tesla and Rivian, and the impact of recent stock drops […]
Leadership Insights and Private Equity Trends with Holly Buckley, Chair of Healthcare at McGuireWoods LLP 10-17-24
In this episode, Holly Buckley, Chair of Healthcare at McGuireWoods, joins Scott Becker to discuss leadership strategies for emerging leaders, trends in the private equity deal market, and the challenges and opportunities within practice management firms. Holly shares her thoughts on communication, trust, and navigating a rapidly evolving healthcare environment.